Table 2 Characteristics of included participants
Study | Mean follow-up,days | Mean age,years | Male,% | CKD,% | AKI | Mean los,days | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incidence,% | Etiology | Stages,% | Progression,% | RRT,% | Duration,days | In-patient,% | Follow-up,% | ||||||
Hodgson2018 [23] | Discharge | 74.2 | NA | NA | 7.2 | NA | NA | 6.1 | NA | NA | 14.4 | 23.0 | NA |
Kolhe2015 [22] | 134 | 76.9 | 50.0 | NA | NA | Pre renal 71.9 %, renal 9.8 %, post renal 4.5 % | Stage-1 54.1 Stage-2 25.1 Stage-3 20.8 | 6.3 | NA | NA | 11.9 | 22.4 | 30.2 |
Kolhe2016 [19] | 171 | 76.3 | 49.0 | NA | NA | Pre renal 56.8 %, renal 11.1 %, post renal 8.1 % | Stage-1 51.3 Stage-2 26.4 Stage-3 22.3 | 5.7 | 2.9 | NA | 11.2 | 22.9 | 41.8 |
McCoy2010 [24] | NA | 59.5 | 56.2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
McCoy2012 [17] | NA | 59.5 | 56.8 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Selby2019 [18] | 30 | 76.0 | 49.4 | 22.6 | 7.6 | NA | Stage-1 62.22 Stage-2 20.7 Stage-3 17.1 | NA | 5.3 | NA | 9.0 | NA | 24.5 |
Thomas2014 [25] | 1460 | 70.6 | 46.6 | NA | NA | NA | Stage-1 36.0 Stage-2 37.3 Stage-3 26.7 | NA | 7.9 | NA | 18.1 | NA | 59.6 |